期刊
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA
卷 26, 期 1, 页码 17-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.soc.2016.07.010
关键词
HPV; HPV vaccination; Anal cancer; HIV; Immunosuppression
资金
- Merck
- Hologic
Anal cancer is an increasingly common non AIDS-defining cancer among individuals infected with the human immunodeficiency virus (HIV). It is associated with human papillomavirus (HPV). HPV16 is the most common genotype detected in anal cancers. The HPV types detected in anal cancer are included in the 9-valent vaccine. HPV vaccines have demonstrated efficacy in reducing anal precancerous lesions in HIV-infected individuals. Standard treatment has been fluorouracil and mitomycin (or cisplatin) plus radiation. Continued studies are needed to test new treatment strategies in HIV-infected patients with anal cancer to determine which treatment protocols provide the best therapeutic index.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据